Tags

Type your tag names separated by a space and hit enter

[What is the value of the combination atovaquone-proguanil for the clinician?].
Med Trop (Mars). 2002; 62(3):232-6.MT

Abstract

Malarone (atovaquone-proguanil) is a new option now available to French clinicians for prophylaxis and treatment of malaria. Administered by the oral route, malarone is almost 100% effective with few side effects. It is indicated for chemoprophylaxis in travelers entering areas with chloraquine-resistant Plasmodium falciparum. Compliance with prophylactic treatment is enhanced by the low frequency of adverse effects and the need to continue chemoprophylaxis for only 7 days after leaving the endemic area. For curative treatment of malaria, malarone is especially useful in patients with uncomplicated forms of Plasmodium falciparum malaria. This drug combination is also suitable as a stand-by treatment.

Authors+Show Affiliations

Centre de Formation et de Recherche en Médecine et Santé Tropicales, Faculté de Médecine secteur Nord, boulevard Pierre Dramard, 13015 Marseille, France. jpdelmont@mail.ap-hm.fr

Pub Type(s)

English Abstract
Journal Article
Review

Language

fre

PubMed ID

12244917

Citation

Delmont, J. "[What Is the Value of the Combination Atovaquone-proguanil for the Clinician?]." Medecine Tropicale : Revue Du Corps De Sante Colonial, vol. 62, no. 3, 2002, pp. 232-6.
Delmont J. [What is the value of the combination atovaquone-proguanil for the clinician?]. Med Trop (Mars). 2002;62(3):232-6.
Delmont, J. (2002). [What is the value of the combination atovaquone-proguanil for the clinician?]. Medecine Tropicale : Revue Du Corps De Sante Colonial, 62(3), 232-6.
Delmont J. [What Is the Value of the Combination Atovaquone-proguanil for the Clinician?]. Med Trop (Mars). 2002;62(3):232-6. PubMed PMID: 12244917.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [What is the value of the combination atovaquone-proguanil for the clinician?]. A1 - Delmont,J, PY - 2002/9/25/pubmed PY - 2002/10/17/medline PY - 2002/9/25/entrez SP - 232 EP - 6 JF - Medecine tropicale : revue du Corps de sante colonial JO - Med Trop (Mars) VL - 62 IS - 3 N2 - Malarone (atovaquone-proguanil) is a new option now available to French clinicians for prophylaxis and treatment of malaria. Administered by the oral route, malarone is almost 100% effective with few side effects. It is indicated for chemoprophylaxis in travelers entering areas with chloraquine-resistant Plasmodium falciparum. Compliance with prophylactic treatment is enhanced by the low frequency of adverse effects and the need to continue chemoprophylaxis for only 7 days after leaving the endemic area. For curative treatment of malaria, malarone is especially useful in patients with uncomplicated forms of Plasmodium falciparum malaria. This drug combination is also suitable as a stand-by treatment. SN - 0025-682X UR - https://www.unboundmedicine.com/medline/citation/12244917/[What_is_the_value_of_the_combination_atovaquone_proguanil_for_the_clinician]_ DB - PRIME DP - Unbound Medicine ER -